Skip to main content
70°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Horizon Therapeutics
(NQ:
HZNP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Horizon Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
Next >
Rule 17(e) Announcement - Horizon Therapeutics plc
October 06, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High
October 05, 2023
Via
Investor Brand Network
Rule 17(d) Announcement – Horizon Therapeutics plc
October 05, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
October 03, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High
October 03, 2023
Via
Investor Brand Network
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
October 02, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
October 02, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
September 29, 2023
From
Horizon Therapeutics plc
Via
Business Wire
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
September 29, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
September 27, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics PLC (NASDAQ: HZNP) Sets New 52-Week High in Tuesday Session
September 26, 2023
Via
Investor Brand Network
Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry
September 26, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
September 25, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List
September 19, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
September 13, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement
September 06, 2023
From
Horizon Therapeutics plc
Via
Business Wire
3 Growth Stocks to Buy in September
September 06, 2023
As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings
Via
MarketBeat
Topics
Economy
Exposures
Economy
Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
September 05, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition
September 01, 2023
From
Horizon Therapeutics plc and Amgen
Via
Business Wire
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
August 23, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Drinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners
August 11, 2023
A handful of large caps have taken things to another level. These three stocks have blown past the herd — and may be market leaders for years to come.
Via
MarketBeat
Topics
Bankruptcy
Economy
Exposures
Economy
Financial
Legal
Horizon Therapeutics plc - Rule 2.12 Announcement
August 09, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results
August 08, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Is Growth Priced into Amgen Stock after Earnings Beat?
August 07, 2023
Amgen earnings delivered a solid earnings report after the market closed but analyst sentiment suggests that growth may already be priced into AMGN stock.
Via
MarketBeat
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
July 28, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Announces 2023 #RAREis Global Advocate Grant Recipients
July 27, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Daxdilimab for the Treatment of Systemic Lupus Erythematosus (SLE) Did Not Meet Primary Endpoint
July 21, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc to Release Second-Quarter 2023 Financial Results on Aug. 8, 2023
July 17, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Activision Surges 10% As Judge OK's Microsoft Acquisition Deal
July 12, 2023
Following a federal judge's OK of Microsoft's acquisition, Activision shares soared 10%, marking their strongest performance in over a year. The FTC can appeal.
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.